Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.86 USD | +3.63% |
|
+8.82% | +299.26% |
Business Summary
Number of employees: 11
Managers
Managers | Title | Age | Since |
---|---|---|---|
Punit Dhillon
CEO | Chief Executive Officer | 44 | 19/18/19 |
Director of Finance/CFO | - | 05/21/05 | |
Chief Tech/Sci/R&D Officer | 52 | 13/22/13 | |
Karam Takhar
IRC | Investor Relations Contact | - | - |
Rhea Williams
LAW | General Counsel | - | 07/21/07 |
Thomas S. Kim
LAW | General Counsel | - | - |
Tu Diep
PRN | Corporate Officer/Principal | 43 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 77 | 07/20/07 | |
Praveen Tyle
BRD | Director/Board Member | 64 | 22/21/22 |
Andrew Schwab
BRD | Director/Board Member | 53 | 18/23/18 |
Paul Grayson
BRD | Director/Board Member | - | 18/23/18 |
Punit Dhillon
CEO | Chief Executive Officer | 44 | 19/18/19 |
Keith Ward
BRD | Director/Board Member | 54 | 14/21/14 |
Deborah Charych
BRD | Director/Board Member | - | 14/23/14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 28,067,907 | 26,079,747 ( 92.92 %) | 0 | 92.92 % |
Company contact information
![address Skye Bioscience, Inc.(EMBI)](https://cdn.zonebourse.com/static/address/111314073.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+299.26% | 305M | |
+38.66% | 52.85B | |
-7.81% | 38.87B | |
+35.48% | 38.24B | |
-10.77% | 26.79B | |
+11.77% | 26.16B | |
-17.82% | 19.9B | |
+35.09% | 13.18B | |
+29.17% | 12.24B | |
-3.05% | 11.79B |
- Stock Market
- Equities
- EMBI Stock
- Company Skye Bioscience, Inc.